Note: Ingredients listed on restricted chemical lists
EC/CAS
232-674-9/9004-34-6
Name of the chemical
cellulose
Concentration
5-20
EC/CAS
13463-67-7
Name of the chemical
Reaction mass of titanium dioxide and silver chloride
Concentration
#3_T_CONCENTRATION
EC/CAS
240-589-3/9004-65-3
Name of the chemical
methylhydroxypropylcellulose
Concentration
*
EC/CAS
209-150-3
Name of the chemical
Aluminium, zinc, magnesium and calcium stearates
Concentration
*
EC/CAS
236-675-5
Name of the chemical
Titandioxid; [in Pulverform mit mindestens 1 % Partikel mit aerodynamischem Durchmesser ≤ 10 μm] (2020/217)
Concentration
*
General Information
Version
6
Revision date
2025-06-16
Product name
Dacomitinib Tablets
Product name
Dacomitinib Tablets
Identification on the label/Trade name
VIZIMPRO
Chemical name
Not determined
1.2.1 Relevant identified uses
Pharmaceutical product for the treatment of cancer
Icons in SDS
Company Information
company name
Pfizer Inc
e-mail address of the competent person responsible for the Safety Data Sheet
pfizer-MSDS@pfizer.com
GHS Information
Signal word
Danger
Hazard Codes
Hazard statements (CLP)
H317, H372, H400, H410
Hazard statements
Code
Statements
H317
May cause an allergic skin reaction
Section 2
SECTION 2: Hazards identification
OSHA Classification of the substance or mixture
2.3 Other hazards
Not applicable (HNOC) An Occupational Exposure Value has been established for one or more of the ingredients (see Section 8).
Signal word
Danger
Hazard statements
H317 - May cause an allergic skin reaction H372 - Causes damage to organs through prolonged or repeated exposure: eye, skin, kidneys, liver. H400 - Very toxic to aquatic life H410 - Very toxic to aquatic life with long lasting effects
Precautionary statements
P260 - Do not breathe dust/fume/gas/mist/vapors/spray P264 - Wash hands thoroughly after handling P272 - Contaminated work clothing should not be allowed out of the workplace P270 - Do not eat, drink or smoke when using this product P280 - Wear protective gloves/protective clothing/eye protection/face protection P333 + P313 - If skin irritation or rash occurs: Get medical advice/attention P363 - Wash contaminated clothing before reuse P314 - Get medical advice/attention if you feel unwell P273 - Avoid release to the environment P391 - Collect spillage P501 - Dispose of contents/container in accordance with local, regional, national, and international regulations as applicable P302 + P352 - IF ON SKIN: Wash with plenty of soap and water
PBT Substances
& vPvB The product does not contain any substance(s) classified as PBT or vPvB. Endocrine Disruptor Information This product does not contain any known or suspected endocrine disruptors. Note This document has been prepared in accordance with standards for workplace safety, which require the inclusion of all known hazards of the product or its ingredients regardless of the potential risk. The precautionary statements and warnings included may not apply in all cases. Your needs may vary depending upon the potential for exposure in your workplace.
2.1 Classification of the substance or mixture
GHS - Classification: Regulated according to Regulation (EC) 1272/2008 and/or other applicable regulations. Skin sensitization Category 1 - H317 Specific target organ toxicity (repeated exposure) Category 1 - H372 Hazardous to the aquatic environment - acute Category 1 - H400 Hazardous to the aquatic environment - chronic Category 1 - H410 OSHA Classification Hazards not otherwise classified (HNOC) Not applicable Hazards classified under paragraph (d)(1)(ii) of 1910.1200 Not applicable
